10-K Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001213900-23-022463`
Period End Date	20221231
Filing Date	20230323
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	f10k2022_relmadatherap_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 58 Income Statement 28 Cash Flow Statement 56 Stockholders Equity 20

Balance Sheet 58 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.40M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$167.47M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$142.93M	USD	Point-in-time
Lease payments receivable short term	`ShortTermOfLeasePaymentsReceivable`	$86.38K	USD	Point-in-time
Lease payments receivable short term	`ShortTermOfLeasePaymentsReceivable`	-	USD	Point-in-time
Other Receivables	`ReceivablesNetCurrent`	-	USD	Point-in-time
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other Receivables	`ReceivablesNetCurrent`	$512.43K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.04M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$11.30M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Total current assets	`AssetsCurrent`	$223.30M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$152.87M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	-	shares	Point-in-time
Preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	-	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$28.29K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$34.88K	USD	Point-in-time
Total assets	`Assets`	$223.33M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$152.91M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.10M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.74M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.19M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.26M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.10M	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.21M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.87M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.74M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.47M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.47M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.06M	USD	Point-in-time
Commitments and Contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 30,099,203 and 27,740,147 shares issued and outstanding, respectively	`CommonStockValue`	$30.10K	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 30,099,203 and 27,740,147 shares issued and outstanding, respectively	`CommonStockValue`	$27.74K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$513.30M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$602.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-462.11M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-305.07M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$140.44M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$208.26M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$105.58M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$152.91M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$223.33M	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
Net loss per common share Diluted	`EarningsPerShareDiluted`	$-5.30	USD	Annual
Net loss per common share Diluted	`EarningsPerShareDiluted`	$-7.16	USD	Annual
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	17.55M	shares	Annual
Research and development	`ResearchAndDevelopmentExpense`	$90.62M	USD	Annual
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	29.63M	shares	Annual
Research and development	`ResearchAndDevelopmentExpense`	$113.32M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$47.93M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$35.08M	USD	Annual
Total operating expenses	`OperatingExpenses`	$161.25M	USD	Annual
Total operating expenses	`OperatingExpenses`	$125.70M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-125.70M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-161.25M	USD	Annual
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	$6.35M	USD	Annual
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	-	USD	Annual
Interest/investment income, net	`InterestIncomeExpenseNet`	$1.20M	USD	Annual
Interest/investment income, net	`InterestIncomeExpenseNet`	$2.66M	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-636.01K	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-585.52K	USD	Annual
Unrealized loss on short-term investments	`UnrealizedGainLossOnInvestments`	$-611.38K	USD	Annual
Unrealized loss on short-term investments	`UnrealizedGainLossOnInvestments`	$-4.22M	USD	Annual
Total other income (expenses), net	`NonoperatingIncomeExpense`	$-48.32K	USD	Annual
Total other income (expenses), net	`NonoperatingIncomeExpense`	$4.21M	USD	Annual
Net loss	`NetIncomeLoss`	$-157.04M	USD	Annual
Net loss	`NetIncomeLoss`	$-125.75M	USD	Annual
Net loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-5.30	USD	Annual
Net loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-7.16	USD	Annual
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	29.63M	shares	Annual
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	17.55M	shares	Annual

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-157.04M	USD	Annual
Net loss	`NetIncomeLoss`	$-125.75M	USD	Annual
Depreciation expense	`Depreciation`	$1.26K	USD	Annual
Depreciation expense	`Depreciation`	-	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$40.49M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$44.19M	USD	Annual
Gain on settlement	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Gain on settlement	`GainsLossesOnExtinguishmentOfDebt`	$6.35M	USD	Annual
Realized loss on short-term investments	`IncomeLossFromEquityMethodInvestments`	$-585.52K	USD	Annual
Realized loss on short-term investments	`IncomeLossFromEquityMethodInvestments`	$-636.01K	USD	Annual
Unrealized loss on short-term investments	`UnrealizedsLossgainOnShorttermInvestments`	$-4.22M	USD	Annual
Unrealized loss on short-term investments	`UnrealizedsLossgainOnShorttermInvestments`	$-611.38K	USD	Annual
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-86.38K	USD	Annual
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-79.46K	USD	Annual
Other receivable	`IncreaseDecreaseInAccountsReceivable`	$512.43K	USD	Annual
Other receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$10.40M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-7.26M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$421.04K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.85M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$3.34M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-388.56K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-91.87M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-103.80M	USD	Annual
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$222.98M	USD	Annual
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$47.29M	USD	Annual
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$168.86M	USD	Annual
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$67.03M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$19.73M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-54.12M	USD	Annual
Payment of fees for warrants issued for common stock	`RepaymentsOfNotesPayable`	$50.00K	USD	Annual
Payment of fees for warrants issued for common stock	`RepaymentsOfNotesPayable`	-	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$42.73M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$184.64M	USD	Annual
Proceeds from options exercised for common stock	`ProceedsFromOptionsExercisedForCommonStock`	$668.43K	USD	Annual
Proceeds from options exercised for common stock	`ProceedsFromOptionsExercisedForCommonStock`	$703.72K	USD	Annual
Proceeds from warrants exercised for common stock	`CashlessEexerciseOfWarrants`	$1.26M	USD	Annual
Proceeds from warrants exercised for common stock	`CashlessEexerciseOfWarrants`	$2.63M	USD	Annual
Proceeds from short swing profit, net	`ProceedsFromShortSwingProfitNet`	$-373.63K	USD	Annual
Proceeds from short swing profit, net	`ProceedsFromShortSwingProfitNet`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$45.02M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$187.94M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-39.05M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$41.95M	USD	Annual
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.40M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.40M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Forgiveness of accounts payable related to gain	`ForgivenessOfAccountsPayableRelatedToGain`	-	USD	Annual
Forgiveness of accounts payable related to gain	`ForgivenessOfAccountsPayableRelatedToGain`	$3.21M	USD	Annual
Share exchange for Pre-funded warrants	`CashlessExerciseOfWarrantsForCommonStock`	$1.45K	USD	Annual
Share exchange for Pre-funded warrants	`CashlessExerciseOfWarrantsForCommonStock`	-	USD	Annual
Net exercise of Pre-funded warrants	`CashlessExerciseOfOptionsForCommonStock`	$-1.45K	USD	Annual
Net exercise of Pre-funded warrants	`CashlessExerciseOfOptionsForCommonStock`	-	USD	Annual

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$140.44M	USD	Point-in-time
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Stock-based compensation expense	`StockIssuedDuringPeriodValueShareBasedCompensation`	$40.49M	USD	Annual
Stock-based compensation expense	`StockIssuedDuringPeriodValueShareBasedCompensation`	$44.19M	USD	Annual
ATM offering, net	`ProceedsFromIssuanceInitialPublicOffering`	$42.73M	USD	Annual
Share exchange -Prefunded warrants, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$-50.00K	USD	Annual
Net exercise -Prefunded warrants	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$7.00K	USD	Annual
Equity offering, net	`StockIssuedDuringPeriodValueOther`	$161.23M	USD	Annual
Warrants exercised	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$1.26M	USD	Annual
Warrants exercised	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$23.42M	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfWarrants`	$2.63M	USD	Annual
Options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$668.43K	USD	Annual
Options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$703.72K	USD	Annual
Short swing profit, net	`NetIncomeAmount`	$373.63B	USD	Annual
Net loss	`NetIncomeLoss`	$-157.04M	USD	Annual
Net loss	`NetIncomeLoss`	$-125.75M	USD	Annual
Balance	`StockholdersEquity`	$140.44M	USD	Point-in-time
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.